Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 3, 2001, Pages 649-655

  Inoue, Akira ^a   Kunitoh, Hideo ^a   Sekine, Ikuo ^a   Sumi, Minako ^a   Tokuuye, Koichi ^a   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Corticosteroid; Lung cancer; Prognosis; Radiation pneumonitis; Risk factor

Indexed keywords

CISPLATIN; CORTICOSTEROID; ETOPOSIDE; IRINOTECAN; MITOMYCIN C; PREDNISOLONE; VINDESINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OXYGEN THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION PNEUMONIA; RISK FACTOR; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035283931     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00783-5     Document Type: Article

References (23)

1. Cancer statistics
2. Combined modality therapy for small cell lung cancer
3. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small- cell lung cancer
4. Radiation and the lung; A reevaluation of the mechanisms mediating pulmonary injury
5. Injury to the lung from cancer therapy; Clinical syndromes, measurable endpoints, and potential scoring systems
6. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer
7. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis
8. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma
9. Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis
10. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer
11. Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage; A prospective clinical study
12. Radiation pneumonitis following combined modality therapy for lung cancer; Analysis of prognostic factors
13. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage 3 non-small-cell lung cancer
14. Improved survival in stage 3 non-small-cell lung cancer; seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial
15. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
16. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
17. A preliminary report; Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer
18. Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non-small cell lung cancer
19. Multimodel therapy for limited small-cell lung cancer; A randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; And with wide-field versus reduced-field radiation in partial responders: A Southwest Oncology Group study
20. Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide; A randomized trial of the North Central Cancer Treatment Group
21. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma; A Southwest Oncology Group study
22. Radiotherapy combined with low-dose cis-diammine dichloroplatinum(2) (CDDP) in inoperable non-metastatic non-small cell lung cancer(NSCLC); A randomized three arm phase 2 study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups
23. Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer